Holen Sie sich die Stockscreener-App
38.92
1.38%
0.53
Handel nachbörslich:
38.92
Schlusskurs vom Vortag:
$38.39
Offen:
$38.57
24-Stunden-Volumen:
3.16M
Relative Volume:
0.77
Marktkapitalisierung:
$16.63B
Einnahmen:
$2.31B
Nettoeinkommen (Verlust:
$1.66B
KGV:
16.94
EPS:
2.297
Netto-Cashflow:
$827.02M
1W Leistung:
-0.61%
1M Leistung:
+3.84%
6M Leistung:
+18.55%
1J Leistung:
+47.42%
1-Tages-Spanne:
$38.31
$39.13
1-Wochen-Bereich:
$37.77
$39.69
52-Wochen-Spanne:
$24.05
$41.24
Royalty Pharma Plc Stock (RPRX) Company Profile
Firmenname
Royalty Pharma Plc
Sektor
Branche
Telefon
(212) 883-0200
Adresse
110 EAST 59TH STREET, NEW YORK, NY
Vergleichen Sie RPRX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RPRX
Royalty Pharma Plc
|
38.92 | 16.40B | 2.31B | 1.66B | 827.02M | 2.297 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Royalty Pharma Plc Stock (RPRX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-30 | Eingeleitet | Goldman | Buy |
| 2025-05-16 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-06-03 | Herabstufung | UBS | Buy → Neutral |
| 2022-06-14 | Fortgesetzt | UBS | Buy |
| 2022-05-13 | Eingeleitet | Scotiabank | Sector Outperform |
| 2022-04-27 | Eingeleitet | Goldman | Buy |
| 2022-04-14 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2022-04-06 | Fortgesetzt | Morgan Stanley | Overweight |
| 2021-10-29 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-07-30 | Eingeleitet | Tigress Financial | Buy |
| 2020-11-09 | Hochstufung | UBS | Neutral → Buy |
| 2020-07-14 | Eingeleitet | Evercore ISI | In-line |
| 2020-07-13 | Eingeleitet | BofA Securities | Buy |
| 2020-07-13 | Eingeleitet | Citigroup | Neutral |
| 2020-07-13 | Eingeleitet | Cowen | Outperform |
| 2020-07-13 | Eingeleitet | Goldman | Neutral |
| 2020-07-13 | Eingeleitet | JP Morgan | Neutral |
| 2020-07-13 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2020-07-13 | Eingeleitet | SunTrust | Buy |
| 2020-07-13 | Eingeleitet | UBS | Neutral |
Alle ansehen
Royalty Pharma Plc Aktie (RPRX) Neueste Nachrichten
Royalty Pharma (NASDAQ:RPRX) EVP George Lloyd Sells 132,426 Shares - MarketBeat
Royalty Pharma PLC $RPRX Shares Sold by Brandywine Global Investment Management LLC - MarketBeat
ABN AMRO Bank N.V. Buys New Shares in Royalty Pharma PLC $RPRX - MarketBeat
Can WPIL Limited Deliver Through Market Peaks and TroughsVolume Profile Analysis & Start Investing With Free Smart Watchlists - earlytimes.in
Royalty Pharma Insider Sold Shares Worth $5,192,656, According to a Recent SEC Filing - MarketScreener
Empowered Funds LLC Cuts Stock Position in Royalty Pharma PLC $RPRX - MarketBeat
Terrance Coyne Sells 69,594 Shares of Royalty Pharma (NASDAQ:RPRX) Stock - MarketBeat
Why Royalty Pharma plc (RPD) stock could break out in 2025 - newser.com
TD Cowen Downgrades Royalty Pharma (NASDAQ:RPRX) to Hold - MarketBeat
How Royalty Pharma plc (RPD) stock compares with top peersGold Moves & Short-Term Swing Trade Alerts - newser.com
SG Americas Securities LLC Acquires 15,218 Shares of Royalty Pharma PLC $RPRX - MarketBeat
Connor Clark & Lunn Investment Management Ltd. Takes $626,000 Position in Royalty Pharma PLC $RPRX - MarketBeat
Catalyst Funds Management Pty Ltd Trims Stock Position in Royalty Pharma PLC $RPRX - MarketBeat
Applying chart zones and confluence areas to Royalty Pharma plc2025 Geopolitical Influence & High Accuracy Investment Signals - newser.com
What macro factors could drive Royalty Pharma plc (RPD) stock higher2025 Price Action Summary & Momentum Based Trading Ideas - newser.com
Top chart patterns to watch in Royalty Pharma plcJuly 2025 Institutional & Fast Gain Stock Trading Tips - newser.com
VP Lloyd Files To Sell 3,000 Of Royalty Pharma PLC [RPRX] - TradingView
Will Royalty Pharma plc (RPD) stock maintain strong growthTrend Reversal & Precise Buy Zone Identification - newser.com
Royalty Pharma Insider Sold Shares Worth $2,735,329, According to a Recent SEC Filing - MarketScreener
CFO Coyne Sells 69,594 ($2.7M) Of Royalty Pharma PLC [RPRX] - TradingView
[Form 4] Royalty Pharma plc Insider Trading Activity - Stock Titan
What MACD signals say about Royalty Pharma plcPortfolio Growth Summary & Intraday High Probability Setup Alerts - newser.com
Historical volatility pattern of Royalty Pharma plc visualizedTrade Exit Summary & Expert Curated Trade Ideas - newser.com
Will Royalty Pharma plc (RPD) stock hit Wall Street targetsBond Market & Long-Term Growth Portfolio Plans - newser.com
Analyzing net buyer seller activity in Royalty Pharma plcTrade Entry Summary & Fast Gaining Stock Strategy Reports - newser.com
Trading the Move, Not the Narrative: (RPRX) Edition - news.stocktradersdaily.com
Is Royalty Pharma plc (RPD) stock attractive post correctionWall Street Watch & Risk Managed Investment Signals - newser.com
Can Royalty Pharma plc stock rebound after recent weaknessWeekly Market Report & High Accuracy Investment Signals - newser.com
Why analysts remain bullish on Royalty Pharma plc stockShare Buyback & Capital Efficient Trading Techniques - newser.com
Royalty Pharma (RPRX): Is the Stock Undervalued After Higher 2025 Revenue Guidance and Major Buyback Completion? - Yahoo Finance
How Analyst Views on Royalty Pharma Are Shifting With Recent Acquisition and Growth Moves - Yahoo Finance UK
Vise Technologies Inc. Takes Position in Royalty Pharma PLC $RPRX - MarketBeat
Finanzdaten der Royalty Pharma Plc-Aktie (RPRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.36%
1.42%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):